Leukemia Research
Volume 26, Issue 3 , Pages 249-254 , March 2002

Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1

  • Detlef Haase

      Affiliations

    • Department of Hematology and Oncology, Georg-August-University, Robert-Koch-Straße 40, 37075 Göttingen, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-551-39-8535; fax: +49-551-39-8587
    • ,
  • Claudia Binder

      Affiliations

    • Department of Hematology and Oncology, Georg-August-University, Robert-Koch-Straße 40, 37075 Göttingen, Germany
    • ,
  • Jürgen Bünger

      Affiliations

    • Department of Occupational Medicine, Georg-August-University, Waldweg 37, 37073, Göttingen, Germany
    • ,
  • Christa Fonatsch

      Affiliations

    • Institute for Medical Biology, University of Vienna, Währinger Straße 10, 1090 Vienna IX, Austria
    • ,
  • Berthold Streubel

      Affiliations

    • Institute for Medical Biology, University of Vienna, Währinger Straße 10, 1090 Vienna IX, Austria
    • ,
  • Susanne Schnittger

      Affiliations

    • Department of Hematology and Oncology, Ludwig-Maximilians-University, 81377 Munich, Germany
    • ,
  • Frank Griesinger

      Affiliations

    • Department of Hematology and Oncology, Georg-August-University, Robert-Koch-Straße 40, 37075 Göttingen, Germany
    • ,
  • Götz Westphal

      Affiliations

    • Department of Occupational Medicine, Georg-August-University, Waldweg 37, 37073, Göttingen, Germany
    • ,
  • Claudia Schoch

      Affiliations

    • Department of Hematology and Oncology, Ludwig-Maximilians-University, 81377 Munich, Germany
    • ,
  • Agnes Knopp

      Affiliations

    • Department of Hematology and Oncology, University of Rostock, E.-Heydemann-Straße 6, 18055 Rostock, Germany
    • ,
  • Dinko Berkovicz

      Affiliations

    • Department of Hematology and Oncology, Georg-August-University, Robert-Koch-Straße 40, 37075 Göttingen, Germany
    • ,
  • Otto Krieger

      Affiliations

    • Department of Hematology and Bone Marrow Transplantation, Krankenhaus der Elisabethinen, Fadingerstraße 1, 4010 Linz, Austria
    • ,
  • Bernhard Wörmann

      Affiliations

    • Department of Internal Medicine, Clinics of the City of Braunschweig, Celler Straße 36, 38114 Braunschweig, Germany
    • ,
  • Reinhard Hilgers

      Affiliations

    • Department of Medical Statistics, Georg-August-University, Humboldtallee 32, 37073 Göttingen, Germany
    • ,
  • Ernst Hallier

      Affiliations

    • Department of Occupational Medicine, Georg-August-University, Waldweg 37, 37073, Göttingen, Germany
    • ,
  • Thomas Schulz

      Affiliations

    • Department of Occupational Medicine, Georg-August-University, Waldweg 37, 37073, Göttingen, Germany

Received 23 January 2001 ,Accepted 5 July 2001.

References 

  1. Levine EG, Bloomfield CD. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin. Oncol. 1992;19:47–84
  2. Karp JE, Smith MA. The molecular pathogenesis of treatment-induced (secondary) leukemias: foundations for treatment and prevention. Semin. Oncol. 1997;24:103–113
  3. Ben-Yehuda D, Krichevsky S, Caspi O, Rund D, Polliack A, Abeliovich D, et al. Microsatellite instability and p53 mutations in therapy-related leukemia suggests mutator phenotype. Blood. 1996;88:4296–4303
  4. Felix CA, Walker AH, Lange BJ, Willimas TM, Winick NJ, Cheung N-KV, et al. Association of CYP3A4 genotype with treatment-related leukemia. Proc. Natl. Acad. Sci. USA. 1998;95:13176–13181
  5. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995;30:445–600
  6. Kato S, Bowrnan ED, Harrington AM, Blömeke B, Shields PG. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. Natl. Cancer Res. 1995;87:902–907
  7. Seidegard J, Pero RW, Markowitz MM, Rousch G, Miller DG, Beattle EJ. Isoenzyme(s) of glutathione transferase (class μ) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogen. 1990;11:33–36
  8. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogen. 1993;14:1821–1824
  9. Helzlsouer KJ, Selmin O, Huang H-Y, Strickland PT, Hoffman S, Alberg AJ, et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J. Natl. Cancer Inst. 1998;90:512–518
  10. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet. 1996;347:295–297
  11. Atoyebi W, Kusec R, Fidler C, Peto TEA, Boultwood J, Wainscoat JS. Glutathione S-transferase gene deletions in myelodysplasia. Lancet. 1997;349:1450–1451
  12. Basu T, Gale E, Langabeer S, Linch DC. Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia. Lancet. 1997;349:1450
  13. Haase D, Schulz TG, Wörmann B, Schoch C, Schnittger S, Hallier E, Hiddemann W. Association of GSTM 1-deficiency with complex karyotype abnormalities in patients with de novo AML and MDS and with therapy-induced AML, Blood 1998;92:Suppl.1, abstr. 1280.
  14. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 1982;51:189–199
  15. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al. Proposed revised criteria of the classification of acute myeloid leukemia. Ann. Intern. Med. 1985;103:626–629
  16. Haase D, Feuring-Buske M, Könemann S, Fonatsch C, Troff C, Verbeek W, et al. Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood. 1995;86:2906–2912
  17. ISCN . In:  Mitelman F editors. Guidelines for Cancer Cytogenetics. Supplement to: An International System for Human Cytogenetic Nomenclature. Basel: S. Karger; 1995;
  18. Miller SA, Dykes DD, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 1988;16:1215–1217
  19. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM 1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 1993;85:1159–1164
  20. Pemble SE, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt H, et al. Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 1994;300:271–275
  21. Kempkes M, Wiebel FA, Golka K, Heitman P, Bolt HM. Comparative genotyping and phenotyping of glutathione S-transferase GSTT1. Arch. Toxicol. 1996;70:306–309
  22. Büchner T. Akute myeloische Leukämie. Internist. 1993;37:1008–1012
  23. Hoban PR, Robson CN, Davies SM, Hall AG, Cattan AR, Hickson ID, et al. Reduced topoisomerase II and elevated alpha class glutathione S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C. Biochem. Pharmacol. 1992;43:685–693
  24. Chen G, Waxmann DJ. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent toxicity in human breast cancer cells. Biochem. Pharmacol. 1994;47:1079–1087
  25. Golub TR. The genetics of AML: an Update. American Society of Hematology 1999, pp. 102–19.
  26. Matsunaga T, Sakamaki S, Kuga T, Kuroda H, Kusakabe T, Akiyama T, et al. GST-pi-gene-transduced hematopoietic progenitor cell transplantation overcomes the bone marrow toxicity of cyclophosphamide in mice. Hum. Gene Ther. 2000;10:1671–1681
  27. Villafania A, Anwar K, Amar S, Chie L, Way D, Chung DL, et al. Glutathione-S-transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase. Ann. Clin. Lab. Sci. 2000;30:57–64
  28. Ban N, Takahashi Y, Takayama T, Kura T, Katahira T, Sakamaki S, et al. Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide. Cancer Res. 1996;56:3577–3582

PII: S0145-2126(01)00124-2

Leukemia Research
Volume 26, Issue 3 , Pages 249-254 , March 2002

Article Tools

* Image Usage & Resolution